HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
140536.0,253109,2183-01-08 06:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 72-year-old male admitted to the ICU with biomarkers indicating demand ischemia vs NSTEMI, hypovolemia, and septic picture. The patient has a complex medical history, including COPD, AFib, and hyperglycemia.

Potential medical complications that can arise from the patient's condition include:

1. Respiratory failure: The patient has respiratory failure due to pneumonia and underlying lung disease, which may lead to further complications such as acute respiratory distress syndrome (ARDS) or respiratory arrest.
2. Cardiac complications: The patient's elevated troponin and mildly elevated CK-MB suggest acute myocardial injury, which may lead to cardiac arrhythmias, heart failure, or even cardiac arrest.
3. Septic shock: The patient's septic picture and hypotension may lead to septic shock, which can be life-threatening if not treated promptly.
4. Hypocalcemia: The patient's prolonged QTc and hyponatremia may indicate hypocalcemia, which can lead to cardiac arrhythmias, muscle cramps, and seizures.
5. Drug reactions: The patient's rash and history of drug reaction to lisinopril may indicate an allergic reaction, which can lead to further complications such as anaphylaxis or Stevens-Johnson syndrome.
6. Infection: The patient's pneumonia and septic picture may lead to secondary infections, such as urinary tract infections or bloodstream infections.
7. Neurological complications: The patient's AFib and history of stroke may increase the risk of neurological complications such as stroke, seizure, or cognitive impairment.
8. Gastrointestinal complications: The patient's pneumonia and septic picture may lead to gastrointestinal complications such as nausea, vomiting, or gastrointestinal bleeding.

Given the patient's complex medical history and current condition, it is essential to closely monitor his vital signs, laboratory results, and medication administration to prevent and manage potential complications."
140536.0,253109,2183-01-08 06:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - CXR in AM, f/u on final
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications can arise:

1. Respiratory failure: The patient has a history of chronic obstructive pulmonary disease (COPD) and is currently intubated with a respiratory rate of 9 breaths per minute. There is a risk of respiratory failure due to pneumonia and underlying lung disease.
2. Septic shock: The patient has a septic picture with elevated white blood cell count, and there is a risk of septic shock if not treated promptly.
3. Cardiac complications: The patient has elevated troponin levels, suggesting acute myocardial injury. There is a risk of cardiac complications, such as arrhythmias, heart failure, and cardiogenic shock.
4. Hypotension: The patient has hypotension, which can worsen if not treated promptly.
5. Hyponatremia: The patient has hyponatremia, which can be caused by volume loss or SIADH.
6. Prolonged QTc: The patient has a prolonged QTc interval, which can increase the risk of arrhythmias.
7. Rash: The patient has a rash, which can be caused by a drug reaction or allergic reaction. There is a risk of skin complications, such as toxic epidermal necrosis.
8. Hyperglycemia: The patient has hyperglycemia, which can worsen if not treated promptly.
9. Glaucoma: The patient has glaucoma, which can worsen if not treated promptly.

The patient's condition is complex and requires close monitoring and management. The following interventions are recommended:

1. Continue respiratory support with intubation and mechanical ventilation.
2. Treat sepsis with antibiotics and fluids as needed.
3. Monitor cardiac status and treat any cardiac complications promptly.
4. Manage hypotension with fluids and vasopressors as needed.
5. Correct hyponatremia with normal saline and monitor electrolyte levels.
6. Monitor QTc interval and treat any arrhythmias promptly.
7. Consult dermatology for further evaluation and management of the rash.
8. Monitor blood glucose levels and treat hyperglycemia with insulin as needed.
9. Manage glaucoma with topical medications and monitor eye pressure.

The patient's code status is full code, and the disposition is ICU care."
140536.0,253109,2183-01-08 06:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Changed antibiotics
 vanc/cefepime
   [**Known lastname 13180**], [**Known firstname **]
    [**Numeric Identifier 13181**]
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds, intubated
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72yo M p/w +biomarkers in the setting of LLL PNA due
   to demand ischemia vs NSTEMI.  Hypovolemia vs septic picture.
   24 Hour Events:
 INVASIVE VENTILATION - START [**2183-1-7**] 06:24 PM
 MULTI LUMEN - START [**2183-1-7**] 06:51 PM
 ARTERIAL LINE - START [**2183-1-7**] 10:04 PM
   Changed antibiotics
 vanc/cefepime
   [**Known lastname 13180**], [**Known firstname **]
    [**Numeric Identifier 13181**]
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 600 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 06:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 41 (37 - 54) bpm
   BP: 113/60(77) {102/57(76) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 14 (14 - 14)mmHg
   Total In:
                                                                    638 mL
                                                                  1,028 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,028 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    280 mL
   Urine:
                                                                    125 mL
                                                                    280 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    748 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 945 (945 - 945) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 9
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 13
   PIP: 11 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 8.1 L/min
   PaO2 / FiO2: 332
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : ), coarse breath sounds, intubated
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Musculoskeletal: No(t) Muscle wasting
   Skin:  Warm, Rash: diffuse
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Fluid analysis / Other labs: UA pending
   Imaging: CXR: wetread: ETT tip 4.5c from carina, NGH & sidehole over
   stomach R PICC tip mid SVC, Low lung vol Retrocardic opacities
   Microbiology: Sputum culture pending
   Urine culture pending
   Blood culture x3 pending
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition: NPO
   Glycemic Control:  ISS
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: famotidine
   VAP:  abx
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 72-year-old male admitted to the ICU with a diagnosis of pneumonia due to demand ischemia vs NSTEMI, with a possibility of septic shock. The patient has been treated with antibiotics, heparin, and other medications.

The patient's vital signs are stable, with a temperature of 36°C (96.8°F), heart rate of 41 bpm, and blood pressure of 113/60 mmHg. The patient is intubated and receiving mechanical ventilation.

The patient's laboratory results show elevated biomarkers, including troponin and CK-MB, indicating possible cardiac injury. The patient's cardiac enzymes are trending upward, and the patient is being monitored for cardiac complications.

The patient has a history of COPD, and his treatment includes bronchodilators and corticosteroids. The patient's anemia is unclear in etiology, and further testing is needed to determine the cause.

The patient has a history of alcoholism, and his daughter reports that he has been chronically bradycardiac. The patient has a CHADS2 score of 4, indicating a high risk of stroke, but he is not anticoagulated due to his fall risk.

The patient has a prolonged QTc interval, which may be due to medication side effects, ischemic heart disease, or hypocalcemia. The patient's sodium level is low, likely due to volume loss, and the patient is being treated with fluids.

The patient has a rash that has been present for three months, which is suspected to be a drug reaction to lisinopril. The patient is being treated with antihistamines and corticosteroids.

The patient has a history of ethanol abuse and is being treated with thiamine and folic acid. The patient's blood glucose level is elevated, and he is being treated with insulin.

The patient has a diagnosis of glaucoma and is being treated with Lumigan (Bimatoprost).

The patient's ICU care includes nutrition via nasogastric tube, glycemic control with insulin, and prophylaxis for deep vein thrombosis, stress ulcer, and ventilator-associated pneumonia.

The patient's code status is full code, and his disposition is to remain in the ICU.

Potential medical complications that can arise from the patient's condition include:

1. Cardiac complications: The patient's elevated biomarkers and cardiac enzymes suggest possible cardiac injury, which can lead to cardiac complications such as arrhythmias, heart failure, or cardiac arrest.
2. Respiratory failure: The patient's pneumonia and respiratory failure can lead to worsening respiratory status, which can result in respiratory arrest or failure.
3. Sepsis: The patient's septic shock can lead to organ dysfunction, including cardiac, renal, and hepatic failure.
4. Anemia: The patient's anemia can lead to fatigue, weakness, and shortness of breath.
5. Hyponatremia: The patient's low sodium level can lead to seizures, coma, or even death.
6. Rash: The patient's rash can progress to Stevens-Johnson syndrome or toxic epidermal necrosis, which can be life-threatening.
7. Glaucoma: The patient's glaucoma can lead to blindness if left untreated.
8. Hyperglycemia: The patient's elevated blood glucose level can lead to diabetic ketoacidosis or hyperosmolar nonketotic coma.

It is essential to closely monitor the patient's condition and adjust his treatment plan accordingly to prevent these potential complications and ensure his optimal care."
140536.0,253109,2183-01-08 07:57:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, Pressure Support
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give
   vancomycin/cefepime/azithromycin instead of azithromycin/ceftriaxone he
   received at OSH for HCAP.  LFTs nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses.
   -Continue azithromycin for atypical coverage.
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: IV heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, Pressure Support
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give
   vancomycin/cefepime/azithromycin instead of azithromycin/ceftriaxone he
   received at OSH for HCAP.  LFTs nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses.
   -Continue azithromycin for atypical coverage.
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: IV heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided physician's daily progress note, I will summarize the patient's health progress in the ICU and identify potential medical complications that can arise.

**Summary of Patient's Health Progress:**

The patient is a 72-year-old male admitted to the ICU with a chief complaint of respiratory distress, pneumonia, and possible septic picture. He has a history of COPD, AFib, and EtOH abuse. The patient is intubated and receiving mechanical ventilation with a FiO2 of 40%. His vital signs are stable, with a temperature of 36°C, heart rate of 36-54 bpm, and blood pressure of 109/58 mmHg.

**Potential Medical Complications:**

1. **Pneumonia and Septic Shock:** The patient's pneumonia and possible septic picture can lead to septic shock, which can result in multi-organ dysfunction and increased mortality.
2. **Cardiac Complications:** The patient's elevated troponin and mildly elevated CK-MB suggest possible cardiac injury. The patient's history of AFib and the presence of a high-grade LAD lesion increase the risk of cardiac complications, such as acute myocardial infarction or cardiac arrhythmias.
3. **Respiratory Complications:** The patient's COPD and pneumonia increase the risk of respiratory failure, which can lead to mechanical ventilation dependence and increased mortality.
4. **Gastrointestinal Complications:** The patient's history of EtOH abuse and recent hospitalization increase the risk of gastrointestinal bleeding, pancreatitis, or other gastrointestinal complications.
5. **Rash and Skin Complications:** The patient's rash, which may be related to a drug reaction or toxic epidermal necrosis, can lead to skin complications such as infections, fluid loss, or sepsis.
6. **Hypotension and Shock:** The patient's hypotension and possible septic picture increase the risk of shock, which can lead to multi-organ dysfunction and increased mortality.
7. **Hyperglycemia and Diabetic Ketoacidosis:** The patient's hyperglycemia can lead to diabetic ketoacidosis, which can result in metabolic acidosis, electrolyte imbalances, and increased mortality.
8. **Pain Management:** The patient's need for pain management increases the risk of medication-related complications, such as respiratory depression or gastrointestinal bleeding.

**Plan of Care:**

Based on the patient's complex medical condition, the following plan of care is recommended:

1. **Continue mechanical ventilation:** The patient's FiO2 will be weaned as tolerated, and the ventilator mode will be adjusted to optimize oxygenation and ventilation.
2. **Manage cardiac complications:** The patient's cardiac biomarkers will be trended, and the patient will be monitored for cardiac arrhythmias or acute myocardial infarction.
3. **Manage respiratory complications:** The patient's COPD will be managed with nebs, and the patient will be monitored for signs of respiratory failure.
4. **Manage gastrointestinal complications:** The patient's gastrointestinal symptoms will be managed with anti-emetics and anti-diarrheal medications, and the patient will be monitored for signs of gastrointestinal bleeding or pancreatitis.
5. **Manage rash and skin complications:** The patient's rash will be managed with topical corticosteroids, and the patient will be monitored for signs of skin infections or fluid loss.
6. **Manage hypotension and shock:** The patient's hypotension will be managed with fluids and vasopressors as needed, and the patient will be monitored for signs of shock.
7. **Manage hyperglycemia and diabetic ketoacidosis:** The patient's hyperglycemia will be managed with insulin and other medications as needed, and the patient will be monitored for signs of diabetic ketoacidosis.
8. **Manage pain:** The patient's pain will be managed with opioids and other medications as needed, and the patient will be monitored for signs of medication-related complications.

By following this plan of care, the patient's complex medical condition will be managed, and the risk of medical complications will be minimized."
140536.0,253109,2183-01-08 07:57:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, CPAP
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   PULSES:  Weak 1 DP pules, 2 radial pulses b/l.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   [**1-8**]
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient now on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean
   to FiO2 40%.
   [**1-7**]
   - a-line placed
   - antibiotics changed to cefepime and vancomycin for HCAP
   Allergies:
   Last dose of Antibiotics:
   Vancomycin - [**2183-1-7**] 09:16 PM
   Cefipime - [**2183-1-7**] 10:17 PM
   Infusions:
   Heparin Sodium - 400 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-7**] 11:02 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-8**] 07:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36
C (96.8
   Tcurrent: 36
C (96.8
   HR: 36 (36 - 54) bpm
   BP: 109/58(74) {102/57(74) - 117/65(81)} mmHg
   RR: 9 (9 - 16) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 26 (14 - 26)mmHg
   Total In:
                                                                    638 mL
                                                                  1,333 mL
   PO:
   TF:
   IVF:
                                                                    578 mL
                                                                  1,333 mL
   Blood products:
   Total out:
                                                                    825 mL
                                                                    355 mL
   Urine:
                                                                    125 mL
                                                                    355 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -187 mL
                                                                    978 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 650 (650 - 650) mL
   Vt (Spontaneous): 1,022 (945 - 1,022) mL
   PS : 5 cmH2O
   RR (Set): 12
   RR (Spontaneous): 11
   PEEP: 0 cmH2O
   FiO2: 40%
   RSBI: 13
   PIP: 6 cmH2O
   Plateau: 10 cmH2O
   SpO2: 100%
   ABG: 7.37/37/166/21/-3
   Ve: 10.7 L/min
   PaO2 / FiO2: 415
   Physical Examination
   40%FiO2, CPAP
   GENERAL: Intubated.
   HEENT: NCAT. Sclera anicteric. Pupils 3mm->2mm reactive to light.  No
   xanthalesma.  Dry MM without visible lesions on tongue/lips.
   NECK: Supple without visible JVP.
   CARDIAC: PMI not palpated. Slow rate normal S1, S2. No m/r/g. No
   thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Coarse breath
   sounds bilaterally at anterior and lateral axillary fields. ABDOMEN:
   Soft, ND. Abd aorta not enlarged by palpation. Normal BS.  No
   abdominial bruits.
   EXTREMITIES: No clubbing, cyanosis, edema.  Warm [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **]/l.
   SKIN: Skin demonstrates diffuse/coalescing maculopapular erythematous
   rash with plaques/erosions on extremities and torso.
   PULSES:  Weak 1 DP pules, 2 radial pulses b/l.
   Labs / Radiology
   133 K/uL
   8.8 g/dL
   158 mg/dL
   1.1 mg/dL
   21 mEq/L
   4.1 mEq/L
   32 mg/dL
   104 mEq/L
   132 mEq/L
   25.4 %
   3.3 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
   WBC
   3.2
   3.3
   Hct
   28.8
   25.4
   Plt
   136
   133
   Cr
   1.2
   1.1
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   Glucose
   162
   142
   158
   Other labs: PT / PTT / INR:11.7/104.2/1.0, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:7.5 mg/dL, Mg++:2.1 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72yo M p/w +biomarkers in the setting of LLL PNA due to demand ischemia
   vs NSTEMI.  Hypovolemia vs septic picture.
   .
   # Respiratory distress [**12-31**] PNA, lung disease.  LLL PNA at OSH.  Given
   recent hospitalization in [**October 2182**] we will give vancomycin/cefepime
   instead of azithromycin/ceftriaxone he received at OSH for HCAP.  LFTs
   nml at OSH.
   -Vanc/Cefepime, Vanc trough after 3 doses
   -CXR in AM
   -Continue intubation w/ fentanyl and midalozam.
   -Wean FiO2 as tolerated
   - f/u Sputum Cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA,
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with nebs (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg QID
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   .
   FEN:  intubated, npo.
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with Heparin IV
   -Pain management with  morphine/ntg if needed once extubated (hold home
   neurontin 100mg TID home dose for now)
   -Bowel regimen with  docusate/senna
   -GI PPX: famotidine while NPO
   .
   CODE: Presumed full per OSH report
   .
   COMM: [**Name (NI) **]: [**Telephone/Fax (1) 13170**], [**Telephone/Fax (1) 13171**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2183-1-7**] 06:51 PM
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 72-year-old male who has been admitted to the ICU with a diagnosis of pneumonia, acute myocardial injury, and possible septic shock. The patient has a history of chronic obstructive pulmonary disease (COPD), atrial fibrillation, and ethanol abuse.

The patient's current condition is as follows:

* Respiratory: The patient is intubated and receiving CPAP with a FiO2 of 40%. His ABG shows a pH of 7.37, pCO2 of 37, and pO2 of 166. His respiratory rate is 9-16 breaths per minute.
* Cardiac: The patient has atrial fibrillation with a slow ventricular response. His troponin level is elevated, and his CK-MB level is mildly elevated. He has a history of demand ischemia vs NSTEMI.
* Renal: The patient's creatinine level is 1.2 mg/dL, and his blood urea nitrogen (BUN) level is 21 mg/dL.
* Hematological: The patient's white blood cell count is 3.2 K/uL, and his platelet count is 136 K/uL.
* Skin: The patient has a diffuse, coalescing maculopapular erythematous rash with plaques/erosions on his extremities and torso.

Potential medical complications that can arise from the patient's current condition include:

1. Respiratory failure: The patient's respiratory status is tenuous, and he may require further respiratory support.
2. Cardiac complications: The patient's elevated troponin level and mildly elevated CK-MB level suggest acute myocardial injury. He may be at risk for further cardiac complications, such as cardiac arrhythmias or infarction.
3. Septic shock: The patient's septic picture and elevated lactate level suggest the possibility of septic shock. He may require further treatment with antibiotics and vasopressors.
4. Renal failure: The patient's elevated creatinine level and BUN level suggest potential renal failure. He may require further monitoring and treatment with diuretics or dialysis.
5. Skin complications: The patient's rash may worsen or spread, potentially leading to skin infections or other complications.

Based on the patient's current condition and potential complications, the following plan is suggested:

1. Continue respiratory support with CPAP and consider weaning the patient off the ventilator when his respiratory status improves.
2. Monitor the patient's cardiac status closely and consider further cardiac testing, such as an echocardiogram or cardiac catheterization, to rule out further cardiac complications.
3. Continue antibiotic treatment for the patient's septic picture and consider adding additional antibiotics if necessary.
4. Monitor the patient's renal function closely and consider further treatment with diuretics or dialysis if necessary.
5. Monitor the patient's skin condition closely and consider further treatment with topical or systemic medications if necessary.
6. Continue to monitor the patient's vital signs and lab results closely and adjust treatment accordingly."
140536.0,253109,2183-01-09 07:15:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Pneumonia, demand ischemia
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right DP pulse: Diminished), (Left DP pulse:
   Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles, Ronchi, L>R with mild positive egophony ),
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Skin:  Warm, Rash: diffuse scaling rash.
   Neurologic: sleepy but arousable, oriented x2.
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.  Continue azithromycin to cover atypical
   pathogens, although also less likely because of lobar consolidation.
   - f/u sputum cx
   - check EKG this AM.
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   - Will plan for catheterization tomorrow for likely high grade stenotic
   but non-occlusive disease.
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - continue advair.
   .
   # Anemia: unclear etiology. Likely secondary to alcoholism.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: heparin IV
   Stress ulcer: n/a
   VAP:  n/a
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Pneumonia, demand ischemia
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Head, Ears, Nose, Throat: Normocephalic, OP without lesions
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right DP pulse: Diminished), (Left DP pulse:
   Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles, Ronchi, L>R with mild positive egophony ),
   Abdominal: Soft, Non-tender, No(t) Distended, Obese
   Extremities: Right lower extremity edema: 1+, Left lower extremity
   edema: 1+
   Skin:  Warm, Rash: diffuse scaling rash.
   Neurologic: sleepy but arousable, oriented x2.
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.  Continue azithromycin to cover atypical
   pathogens, although also less likely because of lobar consolidation.
   - f/u sputum cx
   - check EKG this AM.
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   - Will plan for catheterization tomorrow for likely high grade stenotic
   but non-occlusive disease.
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - continue advair.
   .
   # Anemia: unclear etiology. Likely secondary to alcoholism.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT: heparin IV
   Stress ulcer: n/a
   VAP:  n/a
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 72-year-old male who was admitted to the ICU with pneumonia, demand ischemia, and atrial fibrillation. He has a history of COPD, hypertension, and hyperlipidemia. He stopped taking lisinopril and norvasc three months prior to admission and developed a diffuse scaling rash. He was started on azithromycin and cefepime, but his Troponin levels were elevated, suggesting acute myocardial injury. He was also found to have a wall motion abnormality on echocardiogram. The patient is currently being treated with heparin, ASA, and clopidogrel, and is scheduled for cardiac catheterization tomorrow.

Potential Medical Complications:

1. Respiratory failure: The patient's pneumonia and underlying lung disease put him at risk for respiratory failure. His ABG results show a pH of 7.35, which is slightly acidic, and a pCO2 of 39, which is slightly elevated. He is also receiving oxygen therapy to maintain an SpO2 of 99%.
2. Cardiac complications: The patient's demand ischemia and atrial fibrillation put him at risk for cardiac complications. His elevated Troponin levels suggest acute myocardial injury, and his wall motion abnormality on echocardiogram suggests that he may have a high-grade stenotic lesion in his left anterior descending artery.
3. Infection: The patient's pneumonia and rash put him at risk for infection. His WBC count is elevated, and his differential shows a predominance of neutrophils, which suggests that he may have a bacterial infection.
4. Hypotension: The patient's hypotension may be due to his septic picture, and he is at risk for further hypotension if his infection is not adequately treated.
5. Hyperglycemia: The patient's blood glucose levels are elevated, and he is at risk for further hyperglycemia if his diabetes is not adequately managed.
6. Hyponatremia: The patient's sodium levels are low, and he is at risk for further hyponatremia if his fluid status is not adequately managed.
7. Prolonged QTc: The patient's QTc interval is prolonged, and he is at risk for torsades de pointes if his electrolytes are not adequately managed.

Assessment and Plan:

The patient's primary issue is his pneumonia, and he requires further evaluation and treatment for this condition. He also requires further evaluation and treatment for his demand ischemia and atrial fibrillation. He should be closely monitored for signs of cardiac complications, infection, and hypotension. His hyperglycemia and hyponatremia should be managed with insulin and fluid therapy, respectively. His prolonged QTc interval should be monitored and managed with electrolyte therapy as needed."
140536.0,253109,2183-01-09 07:15:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Patient pain free and somnolent this AM.  Describe prior SOB and
   ?chest discomfort beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable.
   [**1-8**]
   - Derm consulted. Said Drug Induced Lupus may persist for days/weeks
   following discontinuation.  Wanted anti-histone antibody, which was
   done at [**Location (un) 250**], found to be negative (<1.0) [**2183-1-1**] 1024.
   - Repeat Troponin decreased from 0.5 to 0.33. CK 77 this AM.
   - Patient on CPAP on FiO2 of 50% with ABG 7.37/37/166. Plan to wean to
   FiO2 40% -->  EXTUBATED at 9am
   - Added back Azithro for atypical coverage PNA, and sent for VZV in
   sputum
   - still sleepy ~2pm ; ABG 7.35/39/79 looks fine
   - urine output ~2pm ~20cc/hr
   - Flu swab negative ; DC flu precautions
   - legionella urinary antigen negative.
   Allergies:
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2183-1-8**] 09:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-9**] 07:14 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 51 (42 - 60) bpm
   BP: 139/63(88) {118/54(5) - 142/71(94)} mmHg
   RR: 11 (9 - 13) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
    CVP: 10 (8 - 287)mmHg
   Total In:
                                                                  2,342 mL
                                                                    106 mL
   PO:
                                                                     60 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  2,282 mL
                                                                     46 mL
   Blood products:
   Total out:
                                                                    930 mL
                                                                    310 mL
   Urine:
                                                                    930 mL
                                                                    310 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,412 mL
                                                                   -204 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   Ventilator mode: Standby
   Vt (Spontaneous): 941 (941 - 1,022) mL
   PS : 5 cmH2O
   RR (Spontaneous): 0
   PEEP: 0 cmH2O
   FiO2: 35%
   RSBI: 10
   PIP: 0 cmH2O
   SpO2: 99%
   ABG: 7.35/39/78.[**Numeric Identifier 181**]/22/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 226
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   136 K/uL
   9.6 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   27.8 %
   7.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
   WBC
   3.2
   3.3
   7.1
   Hct
   28.8
   25.4
   27.8
   Plt
   136
   133
   136
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   .
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. Given recent hospitalization in [**11-6**] will
   give vanc/cefepime for HCAP instead of azithro/CTX that he received at
   OSH. LFTs were normal at OSH. Differential includes viral pna and
   bacterial pna. Contribution from underlying lung disease.
   - vanc/cefepime - check vanc trough after 3 doses, ID approval for
   cefepime
   - check EKG, consider readding azithro to cover atypicals
   - flu DFA
   - CXR in AM, f/u on final
   - consider urine legionella ag
   - RSBI today, consider extubation if doing well, stop fentanyl and
   midazolam this AM
   - wean vent settings
   - f/u sputum cx
   .
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.  For now, will trend CEs.
   -Repeat and trend biomarkers.
   -Follow tele and EKGs
   -Heparin gtt, ASA
   -Clopidrogrel loading dose 300mg and then 75 mg QD
   -Simvastatin 80mg
   .
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   - Hold home medications: fluticasone, Symbicort(budesonide/formoterol)
   .
   # Anemia: unclear etiology. [**Month (only) 51**] be secondary to alcoholism, viral
   pathology, hemolysis
   - consider viral etiology
   - guaiac stool
   - consider HIV test
   - consider hemolysis labs and iron studies.
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   -Follow EKG
   -ASA 325mg daily
   -Hold beta-blockers
   .
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   -follow EKG/telemetry
   -correct lytes PRN
   .
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   -1L NS
   - urine lytes
   .
   # Hypotension. Concerning for septic picture in setting of PNA, will
   treat infection, give fluids as needed, hold on pressors.
   .
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   -Consult Derm
   -Hold on documented derm recs (Desoxiteasone 0.25% cream topical [**Hospital1 7**],
   Loratidine and topical steroid as needed)
   .
   #  EtOH abuse, last drink [**1-5**]
   -On Midazolam for sedation, transition to lorazepam when extubated.
   -thiamine, folic acid
   -lorazepam 2mg q4h per CIWA when extubated
   .
   #  Hyperglycemia
   - Insulin SS.
   .
   # Glaucoma
   -Lumigan (Bimatoprost).
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-7**] 06:53 PM
   Arterial Line - [**2183-1-7**] 10:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 72-year-old male who was admitted to the ICU with a diagnosis of pneumonia due to demand ischemia vs NSTEMI. The patient has a complex medical history, including COPD, anemia, AFib with slow ventricular response, prolonged QTc, and hyponatremia.

The patient's current condition is as follows:

* Respiratory: The patient is still hypoxemic and requires oxygen therapy. The plan is to wean the FiO2 to 40% and then extubate.
* Cardiac: The patient has elevated troponin and mildly elevated CK-MB, suggesting possible acute myocardial injury. The plan is to medically manage the patient and defer cardiac catheterization until the patient's respiratory status is stable.
* Hemodynamic: The patient's blood pressure is stable, and he is receiving heparin and aspirin.
* Renal: The patient's urine output is 20cc/hr, and his creatinine is 1.2 mg/dL.
* Neurological: The patient's neurological status is not assessed due to his sedation.
* Skin: The patient has a rash that has been present for 3 months, which is suspected to be drug-induced lupus erythematosis.

Potential medical complications that can arise from the patient's condition include:

* Respiratory failure: The patient's hypoxemia and respiratory failure can worsen if not properly managed.
* Cardiac complications: The patient's elevated troponin and mildly elevated CK-MB suggest possible acute myocardial injury, which can lead to cardiac complications such as arrhythmias, heart failure, or cardiogenic shock.
* Sepsis: The patient's septic picture, hyponatremia, and hypotension increase his risk of developing sepsis, which can lead to organ dysfunction and failure.
* Skin complications: The patient's rash, suspected to be drug-induced lupus erythematosis, can worsen and lead to skin complications such as skin necrosis, ulcers, or infections.
* Neurological complications: The patient's sedation and lack of neurological assessment increase his risk of developing neurological complications such as seizures, stroke, or encephalopathy.
* Gastrointestinal complications: The patient's prolonged QTc and hyponatremia increase his risk of developing gastrointestinal complications such as nausea, vomiting, or diarrhea.

In conclusion, the patient is a complex case with multiple medical conditions and complications. Close monitoring and management are necessary to prevent and treat potential complications."
140536.0,253109,2183-01-10 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 72-year-old male admitted to the ICU with + biomarkers in the setting of pneumonia due to demand ischemia vs NSTEMI. The patient has a complex medical history, including COPD, anemia, and atrial fibrillation with slow ventricular response.

The patient's current condition is as follows:

* Respiratory status: Hypoxemic with pneumonia and underlying lung disease, likely CAP.
* Cardiovascular status: Elevated troponin and mildly elevated CK-MB, consistent with demand ischemia or NSTEMI. The patient has a high-grade LAD lesion and is likely to have an acute myocardial injury.
* Neurological status: Attentive and oriented, but with a rash that began 3 months ago and is suspected to be a drug reaction to lisinopril or amlodipine.
* Renal status: Hyponatremia likely due to volume loss, and possibly secondary to SIADH given the lung process/stress.
* Endocrine status: Hyperglycemia, requiring insulin sliding scale.
* Gastrointestinal status: Malnutrition, requiring nutrition support.
* Infectious status: Pneumonia, likely CAP, and possibly septic.

The patient is at risk for several medical complications, including:

* Respiratory failure: Given the patient's pneumonia and underlying lung disease, there is a high risk of respiratory failure.
* Cardiac complications: The patient's elevated troponin and mildly elevated CK-MB suggest an acute myocardial injury, which may lead to cardiac complications such as arrhythmias or cardiogenic shock.
* Neurological complications: The patient's rash and suspected drug reaction may lead to neurological complications such as seizures or encephalopathy.
* Renal complications: The patient's hyponatremia and possible SIADH may lead to renal complications such as acute kidney injury or chronic kidney disease.
* Gastrointestinal complications: The patient's malnutrition and possible gut dysfunction may lead to gastrointestinal complications such as diarrhea or constipation.

The patient's treatment plan includes:

* Respiratory support: Oxygen therapy and mechanical ventilation as needed.
* Cardiovascular support: Heparin gtt, ASA, and Clopidrogrel to manage demand ischemia or NSTEMI.
* Neurological support: Triamcinolone cream for the rash and consideration of Ativan for anxiety or agitation.
* Renal support: Regular insulin sliding scale to manage hyperglycemia and consideration of thiamine and folic acid for nutritional support.
* Gastrointestinal support: Nutrition support and consideration of proton pump inhibitors for stress ulcer prophylaxis.
* Infectious disease management: Antibiotics for pneumonia and consideration of antiviral therapy for possible viral pneumonia.

Overall, the patient requires close monitoring and management of his complex medical conditions to prevent complications and improve his outcomes."
140536.0,253109,2183-01-10 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia vs NSTEMI.
   24 Hour Events:
   - Patient pain.  Describe prior SOB and ?chest discomfort
   beginning/worsening after [**Holiday **].
   - Patient says rash began in [**Month (only) 1148**] or [**Month (only) 2139**] and that he stopped
   both lisinopril and norvasc at that time, patient appears confused and
   timecourse is not reliable. Rash is intermittently painful/pruritic.
   -Derm f/u: DiffDx: systemic lupus (SLE) and sub-acute cutaneous lupus
   (SCLE).  B/C his anti-histone antibodies were negative and they are
   positive in about 95% of patients with drug-induced SLE, this is less
   likely.  Anti-histone is often not positive in SCLE.  Anti-Ro antibody
   looking for SCLE.
   - DCed Azithromycin b/c QTc>500
   - Speech and swallow says he'll be OK to eat normal foods after Cath;
   will get thin liquids and ground solids tonight and NPO p MN for cath
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-10**] 07:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 51 (43 - 58) bpm
   BP: 152/74(94) {129/49(69) - 152/78(94)} mmHg
   RR: 12 (10 - 18) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
             Total In:
                                                                    542 mL
                                                                    277 mL
   PO:
                                                                    360 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    182 mL
                                                                     37 mL
   Blood products:
   Total out:
                                                                  1,360 mL
                                                                    400 mL
   Urine:
                                                                  1,360 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -818 mL
                                                                   -123 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No acute distress, Overweight /
   Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present), no left
   femoral bruit, ?R femoral bruit
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : bibasilar coarse breath sounds)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed, Rash: diffuse
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x2
   ([**2183**]), Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   136 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.3 mEq/L
   36 mg/dL
   104 mEq/L
   134 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   Other labs: PT / PTT / INR:10.7/30.7/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.4 mg/dL, PO4:4.6 mg/dL
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia vs NSTEMI.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - discontinue vancomycin, switch back to ceftriaxone from cefepime
   because pseudomonas unlikely.
   - d/c azithromycin - prolonged QT, atypicals less likely
   - f/u sputum cx
   - check EKG this AM
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  Patient has elevated troponin,
   mildly elevated CK-MB (MBI ~ 10).  Given that patient's primary issue
   is his pneumonia and possibly septic picture, will favor medically
   managing for now and defer cardiac cath after resp status is stable.
   The patient liklely has high grade LAD lesion given new WMA, but is not
   likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
   #  Rash has been for 3 months per OSH report. Consider drug reaction to
   lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
   #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
   #  Hyperglycemia
   - Insulin SS
   # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU - possibly to floor later today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications can arise:

1. Respiratory failure: The patient has pneumonia and underlying lung disease, which increases the risk of respiratory failure. The patient's oxygen saturation is 98%, but the note mentions that they are reportedly hypoxemic.
2. Demand ischemia vs NSTEMI: The patient has elevated troponin and mildly elevated CK-MB, indicating possible acute myocardial injury. The patient's primary issue is their pneumonia and possibly septic picture, but they may have a high-grade LAD lesion.
3. Prolonged QTc: The patient has a prolonged QTc interval, which may be caused by medication side effects, ischemic heart disease, or hypocalcemia. The patient is already taking azithromycin, which was discontinued due to QTc prolongation.
4. Anemia: The patient has an unclear etiology of anemia, which may be secondary to alcoholism. The patient's hemoglobin level is 10.1 g/dL, which is low.
5. Hyponatremia: The patient has hyponatremia, which may be due to volume loss or SIADH. The patient's sodium level is 130 mmol/L.
6. Rash: The patient has a rash that has been present for three months, which may be caused by a drug reaction to lisinopril or amlodipine. The patient's rash has been described as diffuse and intermittently painful/pruritic.
7. Glaucoma: The patient has a history of glaucoma and is taking Lumigan (Bimatoprost).
8. Hyperglycemia: The patient has hyperglycemia, with a glucose level of 162 mg/dL. The patient is taking insulin sliding scale.
9. EtOH abuse: The patient has a history of EtOH abuse and is currently experiencing withdrawal symptoms. The patient's last drink was reported to be one to five days ago.

Based on the patient's medical complications, the following potential medical complications can arise:

1. Cardiac arrhythmias: The patient's prolonged QTc interval and history of NSTEMI increase the risk of cardiac arrhythmias.
2. Respiratory arrest: The patient's respiratory failure and pneumonia increase the risk of respiratory arrest.
3. Sepsis: The patient's pneumonia and possibly septic picture increase the risk of sepsis.
4. Cardiac arrest: The patient's demand ischemia vs NSTEMI and prolonged QTc interval increase the risk of cardiac arrest.
5. Worsening of anemia: The patient's anemia may worsen if they do not receive adequate treatment.
6. Worsening of hyponatremia: The patient's hyponatremia may worsen if they do not receive adequate treatment.
7. Increased risk of skin infection: The patient's rash and history of EtOH abuse increase the risk of skin infection.
8. Increased risk of glaucoma complications: The patient's glaucoma and history of EtOH abuse increase the risk of glaucoma complications.
9. Increased risk of hyperglycemia complications: The patient's hyperglycemia and history of EtOH abuse increase the risk of hyperglycemia complications."
140536.0,253109,2183-01-11 05:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), no murmurs, rubs or
   gallops, low JVD
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : diffuse)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Diffuse rash
   Neurologic: Attentive, AOx2
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - d/c CTX, oral cefpodoxime x5days
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - ASA
   - d/c heparin gtt
   - Clopidrogrel
   - Simvastatin 80mg
   - PT consult
   # HTN: restart [**Last Name (un) **], hold metoprolol
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  hyponatremia: likely due to volume loss.  Would also consider SIADH
   given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), no murmurs, rubs or
   gallops, low JVD
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : diffuse)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Diffuse rash
   Neurologic: Attentive, AOx2
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - d/c CTX, oral cefpodoxime x5days
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - ASA
   - d/c heparin gtt
   - Clopidrogrel
   - Simvastatin 80mg
   - PT consult
   # HTN: restart [**Last Name (un) **], hold metoprolol
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  hyponatremia: likely due to volume loss.  Would also consider SIADH
   given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 72-year-old male who presented with positive biomarkers in the setting of pneumonia due to demand ischemia. He underwent a cardiac catheterization, which showed a mid-distal anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA was performed with a cutting balloon, underexpansion, and a 2.75x15mm BMS was placed. He was started on aspirin, clopidogrel, and simvastatin. He has a history of hypertension, COPD, anemia, and atrial fibrillation with a slow ventricular response. He also has a rash that has been present for three months and is suspected to be a drug reaction. He is being treated for pneumonia, hyperglycemia, and hyponatremia.

Potential Medical Complications:

1. Respiratory failure: The patient has pneumonia and underlying lung disease, which puts him at risk for respiratory failure.
2. Cardiac complications: The patient has a history of atrial fibrillation and demand ischemia, which may lead to cardiac complications such as arrhythmias, heart failure, or myocardial infarction.
3. Infection: The patient has pneumonia and is at risk for developing other infections, such as urinary tract infections or sepsis.
4. Bleeding: The patient is taking anticoagulant medications, which may increase his risk of bleeding.
5. Stroke: The patient has a high CHADS2 score, which puts him at risk for stroke.
6. Hypocalcemia: The patient's prolonged QTc may be due to hypocalcemia, which can lead to cardiac arrhythmias.
7. Hyponatremia: The patient's hyponatremia may be due to volume loss or SIADH, which can lead to seizures, coma, or death.
8. Rash: The patient's rash may be a sign of a drug reaction, which can lead to severe skin reactions or systemic complications.
9. Anemia: The patient's anemia may be due to chronic alcoholism, which can lead to malnutrition, weakness, and fatigue.
10. Glaucoma: The patient has a history of glaucoma, which can lead to vision loss if not properly treated.

Recommendations:

1. Continue to monitor the patient's respiratory status and provide oxygen therapy as needed.
2. Monitor the patient's cardiac status and provide medications as needed to prevent cardiac complications.
3. Continue to treat the patient's pneumonia with antibiotics and provide supportive care.
4. Monitor the patient's electrolyte levels and provide supplements as needed to prevent hypocalcemia and hyponatremia.
5. Continue to monitor the patient's rash and provide treatment as needed to prevent severe skin reactions or systemic complications.
6. Provide the patient with nutritional support to address his anemia and malnutrition.
7. Monitor the patient's glaucoma and provide treatment as needed to prevent vision loss."
140536.0,253109,2183-01-11 05:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : basilar)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - continue CTX for now, consider d/c'ing - patient has been afebrile,
   oxygenation improved
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 72-year-old male presents with + biomarkers in setting
   of pneumonia due to demand ischemia.
   24 Hour Events:
   -Cath showed mid-distal anterolateral HK, 1vCAD: mid LAD calcified
   lesion. PTCA w/ cutting balloon, underexpansion. Rotablade w/ 1.5 burr.
   2.75x15mm BMS placed. Postdilated to >20 atm w/ 2.75 NC balloon. Good
   angio result. Right fem angioseal. LVEDP 15-20.
   -on Ntg after cath lab for elevated pressures - will wean aggressively
   -restarted heparin gtt until figure out what to do for atrial
   fibrillation
   Allergies:
   Lisinopril
   Rash;
   Amlodipine
   Rash;
   Last dose of Antibiotics:
   Azithromycin - [**2183-1-8**] 11:00 AM
   Cefipime - [**2183-1-8**] 04:19 PM
   Vancomycin - [**2183-1-8**] 07:24 PM
   Ceftriaxone - [**2183-1-10**] 08:01 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2183-1-11**] 05:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**84**] AM
   Tmax: 36.5
C (97.7
   Tcurrent: 36
C (96.8
   HR: 48 (44 - 65) bpm
   BP: 141/64(85) {123/54(70) - 164/79(99)} mmHg
   RR: 15 (11 - 20) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 93.3 kg (admission): 95 kg
   Height: 70 Inch
             Total In:
                                                                  1,772 mL
                                                                    183 mL
   PO:
                                                                    700 mL
             TF:
   IVF:
                                                                  1,072 mL
                                                                    183 mL
   Blood products:
   Total out:
                                                                  1,335 mL
                                                                    235 mL
   Urine:
                                                                  1,335 mL
                                                                    235 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    437 mL
                                                                    -52 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Crackles : basilar)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   152 K/uL
   10.1 g/dL
   115 mg/dL
   0.9 mg/dL
   25 mEq/L
   4.2 mEq/L
   34 mg/dL
   106 mEq/L
   136 mEq/L
   29.9 %
   6.1 K/uL
        [image002.jpg]
                             [**2183-1-7**]  07:11 PM
                             [**2183-1-7**]  10:13 PM
                             [**2183-1-8**]  12:15 AM
                             [**2183-1-8**]  03:59 AM
                             [**2183-1-8**]  04:22 AM
                             [**2183-1-8**]  01:55 PM
                             [**2183-1-8**]  05:03 PM
                             [**2183-1-9**]  02:55 AM
                             [**2183-1-10**]  06:26 AM
   WBC
   3.2
   3.3
   7.1
   6.1
   Hct
   28.8
   25.4
   27.8
   29.9
   Plt
   136
   133
   136
   152
   Cr
   1.2
   1.1
   1.0
   1.0
   0.9
   TropT
   0.51
   0.33
   TCO2
   22
   23
   22
   22
   Glucose
   162
   142
   158
   136
   115
   Other labs: PT / PTT / INR:10.8/36.5/0.9, CK / CKMB /
   Troponin-T:77/10/0.33, ALT / AST:16/35, Alk Phos / T Bili:58/0.3,
   Differential-Neuts:82.2 %, Lymph:15.1 %, Mono:2.0 %, Eos:0.4 %,
   Ca++:8.0 mg/dL, Mg++:2.6 mg/dL, PO4:4.6 mg/dL
   Imaging: CCATH: Pending. per fellow Cath showed mid-distal
   anterolateral HK, 1vCAD: mid LAD calcified lesion. PTCA w/ cutting
   balloon, underexpansion. Rotablade w/ 1.5 burr. 2.75x15mm BMS placed.
   Postdilated to >20 atm w/ 2.75 NC balloon. Good angio result. Right fem
   angioseal. LVEDP 15-20.
   Microbiology: Blood cx pending
   Urine cx negative
   Respiratory cx normal flora, yeast
   Legionella negative
   DFA negative
   Assessment and Plan
   72-year-old male presents with + biomarkers in setting of pneumonia due
   to demand ischemia.
   #. Respiratory failure: Reportedly hypoxemic. [**12-31**] pneumonia and
   underlying lung disease. LFTs were normal at OSH. Differential includes
   viral pna and bacterial pna. Contribution from underlying lung
   disease.  Negative flu swab and legionella antigen.  Likely CAP even
   though patient had a recent hospitalization, appears to be lobar in
   nature.   Tele shows mild QTc prolongation at 500msec.
   - continue CTX for now, consider d/c'ing - patient has been afebrile,
   oxygenation improved
   - follow up blood cultures
   - follow prolonged QT
   - trend WBC, T
   # Demand ischemia vs NSTEMI:  Given new wall motion abnormality
   consider acute myocardial injury.  The patient liklely has high grade
   LAD lesion given new WMA, but is not likely from acute plaque rupture.
   - Heparin gtt, ASA - until to cath lab
   - Clopidrogrel loading dose 300mg and then 75 mg QD
   - Simvastatin 80mg
   - CCath today
   # COPD: Continue treatment with MDI (ipatropium, albuterol).
   # Anemia: unclear etiology. Likely secondary to alcoholism
   - trend daily
   # Afib with slow ventricular response:  Chronically bradycardiac per
   patient's daughter.  Off [**Name2 (NI) 5863**] agents.  CHADS2 score of 4 (CHF, HTN,
   TIA) concerning for stoke risk, but patient is chronic alcoholic and
   fall risk, thus not anticoagulated.
   - Follow EKG
   - ASA 325mg daily
   - Hold beta-blockers
   # Prolonged QTc. Consider medication side-effect, ischemic heart
   disease and/or hypocalcemia.
   - follow EKG/telemetry
   - correct lytes PRN
   #  Na 130: hyponatremia likely due to volume loss.  Would also consider
   SIADH given lung process/stress.
   - trend chemistry
   - urine lytes
    #  Rash has been for 3 months per OSH report. Consider drug reaction
   to lisinopril per OSH report stopped med. [**2182-12-25**] Derm consult with BX
   suggested focal interface change consistent with drug eruption or
   drug-induced lupus erythematosis.  Drug-induced lupus more likely given
   subsequently positive [**Doctor First Name **].  Derm suggested amlodipine or lisinopril as
   possible culprits.  Family said that rash began as vesicles which
   collesced may be consistent with toxic epidermal necrosis. Also
   consider lichen planus per derm.
   - appreciate Derm consult
   - triamcinolone 0.1% per derm recs
    #  EtOH abuse, last drink [**1-5**]
   - ativan CIWA
   - thiamine, folic acid
    #  Hyperglycemia
   - Insulin SS
    # Glaucoma
   -Lumigan (Bimatoprost)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2183-1-9**] 06:00 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 72-year-old male who presents with positive biomarkers in the setting of pneumonia due to demand ischemia. The patient underwent a cardiac catheterization procedure, which revealed a mid-distal anterolateral high-grade lesion in the left anterior descending artery, and a 2.75x15mm bare metal stent was placed.

The patient's current condition is as follows:

* Vital signs: Temperature 36.5°C, heart rate 48 bpm, blood pressure 141/64 mmHg, respiratory rate 15 breaths per minute, and oxygen saturation 98% on nasal cannula.
* Hemodynamic monitoring: Central venous pressure 15-20 mmHg.
* Fluid balance: Total fluid input 1,772 mL, total fluid output 1,335 mL, with a balance of 437 mL.
* Respiratory support: Nasal cannula oxygen delivery.
* Cardiovascular: Atrial fibrillation with a slow ventricular response.
* Neurological: Alert and oriented, with no focal neurological deficits.
* Laboratory results: White blood cell count 3.2-7.1 x 10^9/L, hemoglobin 10.1-12.5 g/dL, platelet count 136-152 x 10^9/L, troponin-T 0.51-0.33 ng/mL, and creatinine 1.0-1.2 mg/dL.

Potential medical complications that can arise based on the patient's condition include:

* Respiratory failure: The patient's pneumonia and underlying lung disease may lead to respiratory failure.
* Cardiac complications: The patient's atrial fibrillation and demand ischemia may lead to cardiac complications such as cardiogenic shock or cardiac arrhythmias.
* Neurological complications: The patient's atrial fibrillation and hypoxemia may lead to neurological complications such as stroke or seizures.
* Infection: The patient's pneumonia and urinary tract infection may lead to sepsis or septic shock.
* Gastrointestinal bleeding: The patient's use of anticoagulation medications may increase the risk of gastrointestinal bleeding.
* Hyperglycemia: The patient's use of insulin and glucose infusions may lead to hyperglycemia.
* Hypocalcemia: The patient's use of medications such as simvastatin may lead to hypocalcemia.
* Renal failure: The patient's use of medications such as vancomycin may lead to renal failure.

The patient's medications include:

* Antibiotics: Azithromycin, cefipime, vancomycin, and ceftriaxone.
* Antiplatelet agents: Aspirin and clopidogrel.
* Anticoagulation agents: Heparin and warfarin.
* Beta-blockers: Metoprolol.
* Calcium channel blockers: Amlodipine.
* Statins: Simvastatin.
* Insulin.
* Glucagon.
* Thiamine and folic acid.
* Lumigan (bimatoprost).

The patient's laboratory results are pending, including blood cultures, urine cultures, and a complete blood count. The patient's imaging studies, including a computed tomography (CT) scan and a cardiac catheterization procedure, are pending."
